{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T12:31:24Z","timestamp":1723033884283},"reference-count":53,"publisher":"University of Tokushima Faculty of Medicine","issue":"1.2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Invest."],"published-print":{"date-parts":[[2023]]},"DOI":"10.2152\/jmi.70.260","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T22:32:02Z","timestamp":1683757922000},"page":"260-270","source":"Crossref","is-referenced-by-count":1,"title":["Effects of EOS789, a novel pan-phosphate transporter inhibitor, on phosphate metabolism : Comparison with a conventional phosphate binder"],"prefix":"10.2152","volume":"70","author":[{"given":"Kazuya","family":"Tanifuji","sequence":"first","affiliation":[{"name":"Department of Applied Nutrition, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Shiozaki","sequence":"additional","affiliation":[{"name":"Department of Applied Nutrition, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Koike","sequence":"additional","affiliation":[{"name":"Department of Applied Nutrition, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minori","family":"Uga","sequence":"additional","affiliation":[{"name":"Department of Applied Nutrition, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aoi","family":"Komiya","sequence":"additional","affiliation":[{"name":"Department of Applied Nutrition, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuki","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Applied Nutrition, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayami","family":"Higashi","sequence":"additional","affiliation":[{"name":"Department of Applied Nutrition, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Shimohata","sequence":"additional","affiliation":[{"name":"Department of Preventive Environment and Nutrition, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Preventive Environment and Nutrition, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Ishizuka","sequence":"additional","affiliation":[{"name":"Laboratory of Physiology School of Food and Nutritional Sciences, University of Shizuoka, Suruga-ku, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisayoshi","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Laboratory of Physiology School of Food and Nutritional Sciences, University of Shizuoka, Suruga-ku, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Ichida","sequence":"additional","affiliation":[{"name":"Research Division, Chugai Pharmaceutical Co., Ltd. Yokohama, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Ohtomo","sequence":"additional","affiliation":[{"name":"Translational Research Division, Chugai Pharmaceutical Co., Ltd. Research Division, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoshi","family":"Horiba","sequence":"additional","affiliation":[{"name":"Research Division, Chugai Pharmaceutical Co., Ltd. Yokohama, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Department of Applied Nutrition, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"},{"name":"Graduate School of Agriculture, Ryukoku University, Ohtsu, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Segawa","sequence":"additional","affiliation":[{"name":"Department of Applied Nutrition, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"925","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Musgrove J, Wolf M : Regulation and Effects of FGF23 in Chronic Kidney Disease. Annu Rev Physiol 82 : 365-90, 2020","DOI":"10.1146\/annurev-physiol-021119-034650"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Doshi SM, Wish JB : Past, Present, and Future of Phosphate Management. Kidney Int Rep 7 : 688-98, 2022","DOI":"10.1016\/j.ekir.2022.01.1055"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Chan M, Kelly J, Tapsell L : Dietary Modeling of Foods for Advanced CKD Based on General Healthy Eating Guidelines : What Should Be on the Plate? Am J Kidney Dis 69 : 436-50, 2017","DOI":"10.1053\/j.ajkd.2016.09.025"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Duque EJ, Elias RM, Moys?s RMA : Phosphate balance during dialysis and after kidney transplantation in patients with chronic kidney disease. Curr Opin Nephrol Hypertens 31 : 326-31, 2022","DOI":"10.1097\/MNH.0000000000000802"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Vall\u00e9e M, Weinstein J, Battistella M, Papineau R, Moseley D, Wong G : Multidisciplinary Perspectives of Current Approaches and Clinical Gaps in the Management of Hyperphosphatemia. Int J Nephrol Renovasc Dis 14 : 301-11, 2021","DOI":"10.2147\/IJNRD.S318593"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ketteler M, Liangos O, Biggar PH : Treating hyperphosphatemia - current and advancing drugs. Expert Opin Pharmacother 17 : 1873-9, 2016","DOI":"10.1080\/14656566.2016.1220538"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Copland M, Komenda P, Weinhandl ED, McCullough PA, Morfin JA : Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use. Am J Kidney Dis 68 : S24-S32, 2016","DOI":"10.1053\/j.ajkd.2016.05.024"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hernando N, Gagnon K, Lederer E : Phosphate Transport in Epithelial and Nonepithelial Tissue. Physiol Rev 101 : 1-35, 2021","DOI":"10.1152\/physrev.00008.2019"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Marks J : The role of SLC34A2 in intestinal phosphate absorption and phosphate homeostasis. Pflugers Arch 471 : 165-73, 2019","DOI":"10.1007\/s00424-018-2221-1"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Jacquillet G, Unwin RJ : Physiological regulation of phosphate by vitamin D, parathyroid hormone (PTH) and phosphate (Pi). Pflugers Arch 471 : 83-98, 2019","DOI":"10.1007\/s00424-018-2231-z"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kaneko I, Tatsumi S, Segawa H, Miyamoto KI : Control of phosphate balance by the kidney and intestine. Clin Exp Nephrol 21 : 21-6, 2017","DOI":"10.1007\/s10157-016-1359-4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ikuta K, Segawa H, Sasaki S, Hanazaki A, Fujii T, Kushi A, Kawabata Y, Kirino R, Sasaki S, Noguchi M, Kaneko I, Tatsumi S, Ueda O, Wada NA, Tateishi H, Kakefuda M, Kawase Y, Ohtomo S, Ichida Y, Maeda A, Jishage KI, Horiba N, Miyamoto KI : Effect of Npt2b deletion on intestinal and renal inorganic phosphate (Pi) handling. Clin Exp Nephrol 22 : 517-28, 2018","DOI":"10.1007\/s10157-017-1497-3"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ohi A, Hanabusa E, Ueda O, Segawa H, Horiba N, Kaneko I, Kuwahara S, Mukai T, Sasaki S, Tominaga R, Furutani J, Aranami F, Ohtomo S, Oikawa Y, Kawase Y, Wada NA, Tachibe T, Kakefuda M, Tateishi H, Matsumoto K, Tatsumi S, Kido S, Fukushima N, Jishage K, Miyamoto K : Inorganic phosphate homeostasis in sodium-dependent phosphate cotransporter Npt2b+\/?- mice. Am J Physiol Renal Physiol 301 : F1105-13, 2011","DOI":"10.1152\/ajprenal.00663.2010"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Schiavi SC, Tang W, Bracken C, O\u2019Brien SP, Song W, Boulanger J, Ryan S, Phillips L, Liu S, Arbeeny C, Ledbetter S, Sabbagh Y : Npt2b deletion attenuates hyperphosphatemia associated with CKD. J Am Soc Nephrol 23 : 1691-700, 2012","DOI":"10.1681\/ASN.2011121213"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sabbagh Y, O\u2019Brien SP, Song W, Boulanger JH, Stockmann A, Arbeeny C, Schiavi SC : Intestinal npt2b plays a major role in phosphate absorption and homeostasis. J Am Soc Nephrol 20 : 2348-58, 2009","DOI":"10.1681\/ASN.2009050559"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ushiki Y, Kawabe K, Yamamoto-Okada K, Uneuchi F, Asanuma Y, Yamaguchi C, Ohta H, Shibata T, Abe T, Okumura-Kitajima L, Kosai Y, Endo M, Otake K, Munetomo E, Takahashi T, Kakinuma H : Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo [b]thiophene derivatives as gut-selective NaPi2b inhibitors. Bioorg Med Chem Lett 59 : 128572, 2022","DOI":"10.1016\/j.bmcl.2022.128572"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ushiki Y, Kawabe K, Yamamoto-Okada K, Uneuchi F, Asanuma Y, Yamaguchi C, Ohta H, Shibata T, Abe T, Okumura-Kitajima L, Kosai Y, Endo M, Otake K, Munetomo E, Takahashi T, Kakinuma H : Design, synthesis and biological evaluation of novel pyridine derivatives as gutselective NaPi2b inhibitors. Bioorg Med Chem Lett 65 : 128700, 2022","DOI":"10.1016\/j.bmcl.2022.128700"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ushiki Y, Kawabe K, Yamamoto-Okada K, Uneuchi F, Asanuma Y, Yamaguchi C, Ohta H, Shibata T, Abe T, Okumura-Kitajima L, Kosai Y, Endo M, Otake K, Munetomo E, Takahashi T, Kakinuma H : Design, synthesis and biological evaluation of novel indole derivatives as gut-selective NaPi2b inhibitors. Bioorg Med Chem 66 : 116783, 2022","DOI":"10.1016\/j.bmc.2022.116783"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Maemoto M, Hirata Y, Hosoe S, Ouchi J, Uchii M, Takada H, Akizawa E, Yanagisawa A, Shuto S : Development of potent non-acylhydrazone inhibitors of intestinal sodium-dependent phosphate transport protein 2b (NaPi2b). Bioorg Med Chem 71 : 116944, 2022","DOI":"10.1016\/j.bmc.2022.116944"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Maemoto M, Hirata Y, Hosoe S, Ouchi J, Narushima K, Akizawa E, Tsuji Y, Takada H, Yanagisawa A, Shuto S : Discovery of Gut-Restricted Small-Molecule Inhibitors of Intestinal Sodium-Dependent Phosphate Transport Protein 2b (NaPi2b) for the Treatment of Hyperphosphatemia. J Med Chem 65 : 1946-60, 2022","DOI":"10.1021\/acs.jmedchem.1c01474"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Matsuo A, Negoro T, Seo T, Kitao Y, Shindo M, Segawa H, Miyamoto K : Inhibitory effect of JTP-59557, a new triazole derivative, on intestinal phosphate transport in vitro and in vivo. Eur J Pharmacol 517 : 111-9, 2005","DOI":"10.1016\/j.ejphar.2005.05.003"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Maruyama S, Marbury TC, Connaire J, Ries D, Maxwell W, Rambaran C : NaPi-IIb Inhibition for Hyperphosphatemia in CKD Hemodialysis Patients. Kidney Int Rep 6 : 675-84, 2021","DOI":"10.1016\/j.ekir.2020.12.017"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Larsson TE, Kameoka C, Nakajo I, Taniuchi Y, Yoshida S, Akizawa T, Smulders RA : NPT-IIb Inhibition Does Not Improve Hyperphosphatemia in CKD. Kidney Int Rep 3 : 73-80, 2018","DOI":"10.1016\/j.ekir.2017.08.003"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ichida Y, Hosokawa N, Takemoto R, Koike T, Nakatogawa T, Hiranuma M, Arakawa H, Miura Y, Azabu H, Ohtomo S, Horiba N : Significant Species Differences in Intestinal Phosphate Absorption between Dogs, Rats, and Monkeys. J Nutr Sci Vitaminol (Tokyo) 66 : 60-7, 2020","DOI":"10.3177\/jnsv.66.60"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Tsuboi Y, Ichida Y, Murai A, Maeda A, Iida M, Kato A, Ohtomo S, Horiba N : EOS789, panphosphate transporter inhibitor, ameliorates the progression of kidney injury in anti-GBM-induced glomerulonephritis rats. Pharmacol Res Perspect 10 : e00973, 2022","DOI":"10.1002\/prp2.973"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Tsuboi Y, Ohtomo S, Ichida Y, Hagita H, Ozawa K, Iida M, Nagao S, Ikegami H, Takahashi T, Horiba N : EOS789, a novel pan-phosphate transporter inhibitor, is effective for the treatment of chronic kidney disease-mineral bone disorder. Kidney Int 98 : 343-54, 2020","DOI":"10.1016\/j.kint.2020.02.040"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Hill Gallant KM, Stremke ER, Trevino LL, Moorthi RN, Doshi S, Wastney ME, Hisada N, Sato J, Ogita Y, Fujii N, Matsuda Y, Kake T, Moe SM : EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients. Kidney Int 99 : 1225-33, 2021","DOI":"10.1016\/j.kint.2020.09.035"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. King AJ, Siegel M, He Y, Nie B, Wang J, Koo-McCoy S, Minassian NA, Jafri Q, Pan D, Kohler J, Kumaraswamy P, Kozuka K, Lewis JG, Dragoli D, Rosenbaum DP, O\u2019Neill D, Plain A, Greasley PJ, Jonsson-Rylander AC, Karlsson D, Behrendt M, Stromstedt M, Ryden-Bergsten T, Knopfel T, Pastor Arroyo EM, Hernando N, Marks J, Donowitz M, Wagner CA, Alexander RT, Caldwell JS : Inhibition of sodium\/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability. Sci Transl Med 10 : 2018","DOI":"10.1126\/scitranslmed.aam6474"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Block GA, Rosenbaum DP, Leonsson-Zachrisson M, Astrand M, Johansson S, Knutsson M, Langkilde AM, Chertow GM : Effect of Tenapanor on Serum Phosphate in Patients Receiving Hemodialysis. J Am Soc Nephrol 28 : 1933-42, 2017","DOI":"10.1681\/ASN.2016080855"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Furutani J, Segawa H, Aranami F, Kuwahara S, Sugano M, Bannai K, Yamato H, Ito M, Miyamoto K : Dietary inorganic phosphorus regulates the intestinal peptide transporter PepT1. J Ren Nutr 23 : e11-20, 2013","DOI":"10.1053\/j.jrn.2012.02.006"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Segawa H, Yamanaka S, Ito M, Kuwahata M, Shono M, Yamamoto T, Miyamoto K : Internalization of renal type IIc Na-Pi cotransporter in response to a high-phosphate diet. Am J Physiol Renal Physiol 288 : F587-96, 2005","DOI":"10.1152\/ajprenal.00097.2004"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Eto N, Tomita M, Hayashi M : NaPi-mediated transcellular permeation is the dominant route in intestinal inorganic phosphate absorption in rats. Drug Metab Pharmacokinet 21 : 217-21, 2006","DOI":"10.2133\/dmpk.21.217"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Kn\u00f6pfel T, Himmerkus N, G\u00fcnzel D, Bleich M, Hernando N, Wagner CA : Paracellular transport of phosphate along the intestine. American Journal of Physiology-Gastrointestinal and Liver Physiology 317 : G233-G41, 2019","DOI":"10.1152\/ajpgi.00032.2019"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Nagano N, Miyata S, Obana S, Eto N, Fukushima N, Burke SK, Wada M : Renal mineral handling in normal rats treated with sevelamer hydrochloride (Renagel), a noncalcemic phosphate binder. Nephron 89 : 321-8, 2001","DOI":"10.1159\/000046093"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Segawa H, Kaneko I, Yamanaka S, Ito M, Kuwahata M, Inoue Y, Kato S, Miyamoto K : Intestinal Na-P(i) cotransporter adaptation to dietary P(i) content in vitamin D receptor null mice. Am J Physiol Renal Physiol 287 : F39-47, 2004","DOI":"10.1152\/ajprenal.00375.2003"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Kovesdy CP, Adebiyi A, Rosenbaum D, Jacobs JW, Quarles LD : Novel Treatments from Inhibition of the Intestinal Sodium-Hydrogen Exchanger 3. Int J Nephrol Renovasc Dis 14 : 411-20, 2021","DOI":"10.2147\/IJNRD.S334024"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Johansson S, Rosenbaum DP, Knutsson M, Leonsson-Zachrisson M : A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers. Clinical and Experimental Nephrology 21 : 407-16, 2017","DOI":"10.1007\/s10157-016-1302-8"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Lin T, Al-Makki A, Shepler B : Tenapanor : A new treatment option for hyperphosphatemia in end stage kidney disease. J Pharm Pharm Sci 25 : 77-83, 2022","DOI":"10.18433\/jpps32284"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Inaba M, Une Y, Ikejiri K, Kanda H, Fukagawa M, Akizawa T : Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan-A Phase 2 Randomized Trial. Kidney Int Rep 7 : 177-88, 2022","DOI":"10.1016\/j.ekir.2021.11.008"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Shigematsu T, Une Y, Ikejiri K, Kanda H, Fukagawa M, Akizawa T : Therapeutic Effects of Add-On Tenapanor for Hemodialysis Patients with Refractory Hyperphosphatemia. Am J Nephrol 52 : 496-506, 2021","DOI":"10.1159\/000516156"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Pergola PE, Rosenbaum DP, Yang Y, Chertow GM : A Randomized Trial of Tenapanor and Phosphate Binders as a Dual-Mechanism Treatment for Hyperphosphatemia in Patients on Maintenance Dialysis (AMPLIFY). J Am Soc Nephrol 32 : 1465-73, 2021","DOI":"10.1681\/ASN.2020101398"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Akizawa T, Sato Y, Ikejiri K, Kanda H, Fukagawa M : Effect of Tenapanor on Phosphate Binder Pill Burden in Hemodialysis Patients. Kidney Int Rep 6 : 2371-80, 2021","DOI":"10.1016\/j.ekir.2021.06.030"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Cozzolino M, Ketteler M, Wagner CA : An expert update on novel therapeutic targets for hyperphosphatemia in chronic kidney disease : preclinical and clinical innovations. Expert Opin Ther Targets 24 : 477-88, 2020","DOI":"10.1080\/14728222.2020.1743680"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Block GA, Rosenbaum DP, Yan A, Greasley PJ, Chertow GM, Wolf M : The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia. Nephrol Dial Transplant 34 : 339-46, 2019","DOI":"10.1093\/ndt\/gfy061"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Block GA, Rosenbaum DP, Yan A, Chertow GM : Efficacy and Safety of Tenapanor in Patients with Hyperphosphatemia Receiving Maintenance Hemodialysis : A Randomized Phase 3 Trial. J Am Soc Nephrol 30 : 641-52, 2019","DOI":"10.1681\/ASN.2018080832"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Johansson S, Rosenbaum DP, Knutsson M, Leonsson-Zachrisson M : A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers. Clin Exp Nephrol 21 : 407-16, 2017","DOI":"10.1007\/s10157-016-1302-8"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Johansson S, Leonsson-Zachrisson M, Knutsson M, Spencer AG, Labonte ED, Deshpande D, Kohler J, Kozuka K, Charmot D, Rosenbaum DP : Preclinical and Healthy Volunteer Studies of Potential Drug-Drug Interactions Between Tenapanor and Phosphate Binders. Clin Pharmacol Drug Dev 6 : 448-56, 2017","DOI":"10.1002\/cpdd.307"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Block GA, Rosenbaum DP, Leonsson-Zachrisson M, Stefansson BV, Ryden-Bergsten T, Greasley PJ, Johansson SA, Knutsson M, Carlsson BC : Effect of Tenapanor on Interdialytic Weight Gain in Patients on Hemodialysis. Clin J Am Soc Nephrol 11 : 1597-605, 2016","DOI":"10.2215\/CJN.09050815"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Gill R, Nazir TM, Wali R, Sitrin M, Brasitus TA, Ramaswamy K, Dudeja PK : Regulation of rat ileal NHE3 by 1,25(OH)2-vitamin D3. Dig Dis Sci 47 : 1169-74, 2002","DOI":"10.1023\/A:1015071014584"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Nwia SM, Li XC, Leite APO, Hassan R, Zhuo JL : The Na(+)\/H(+) Exchanger 3 in the Intestines and the Proximal Tubule of the Kidney : Localization, Physiological Function, and Key Roles in Angiotensin II-Induced Hypertension. Front Physiol 13 : 861659, 2022","DOI":"10.3389\/fphys.2022.861659"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Zachos NC, Tse M, Donowitz M : MOLECULAR PHYSIOLOGY OF INTESTINAL N+\/H+EXCHANGE. Annual Review of Physiology 67 : 411-43, 2005","DOI":"10.1146\/annurev.physiol.67.031103.153004"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Lu Z, Ding L, Lu Q, Chen Y-H : Claudins in intestines. Tissue Barriers 1 : e24978, 2013","DOI":"10.4161\/tisb.24978"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Hashimoto N, Matsui I, Ishizuka S, Inoue K, Matsumoto A, Shimada K, Hori S, Lee DG, Yasuda S, Katsuma Y, Kajimoto S, Doi Y, Yamaguchi S, Kubota K, Oka T, Sakaguchi Y, Takabatake Y, Hamano T, Isaka Y : Lithocholic acid increases intestinal phosphate and calcium absorption in a vitamin D receptor dependent but transcellular pathway independent manner. Kidney Int 97 : 1164-80, 2020","DOI":"10.1016\/j.kint.2020.01.032"}],"container-title":["The Journal of Medical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/70\/1.2\/70_260\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:34:21Z","timestamp":1715315661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/70\/1.2\/70_260\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":53,"journal-issue":{"issue":"1.2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2152\/jmi.70.260","relation":{},"ISSN":["1343-1420","1349-6867"],"issn-type":[{"value":"1343-1420","type":"print"},{"value":"1349-6867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]}}}